Fluorescence microscopy demonstrates enhanced targeting of telavancin to the division septum of Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 5, 2010, Pages 2198-2200

  Lunde, Christopher S ^a   Rexer, Charles H ^a   Hartouni, Stephanie R ^a   Axt, Sabine ^a,b   Benton, Bret M ^a  

^a THERAVANCE INC   (United States)

^b Achaogen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO ALANINE DEXTRO ALANINE LIGASE; LIPID; TELAVANCIN; VANCOMYCIN;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BINDING AFFINITY; BINDING SITE; BIOSYNTHESIS; CELL DIVISION; CONTROLLED STUDY; DRUG BINDING; DRUG DISTRIBUTION; DRUG TARGETING; FLUORESCENCE MICROSCOPY; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CELL DIVISION; CELL WALL; FLUORESCENT ANTIBODY TECHNIQUE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROSCOPY, FLUORESCENCE; VANCOMYCIN;

EID: 77951224520     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01609-09     Document Type: Article

References (18)

1. Breukink, E., P. P. A. Humphrey, B. M. Benton, and I. Visscher. 2006. Evidence for a multivalent interaction between telavancin and membrane-bound lipid II, abstr. C1-678. Abstr. 46th Intersc. Conf. Antimicrob. Agents Chemother., San Francisco, CA.
2. Clinical Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th ed., M7-A7. Clinical Laboratory Standards Institute, Wayne, PA.
3. Cui, L., H. Murakami, K. Kuwahara-Arai, H. Hanaki, and K. Hiramatsu. 2000. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob. Agents Chemother. 44:2276-2285.
4. Daniel, R. A., and J. Errington. 2003. Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell. Cell 113:767-776.
5. Hegde, S. S., N. Reyes, R. Skinner, and S. Difuntorum. 2008. Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus. J. Antimicrob. Chemother. 61:169-172.
6. Higgins, D. L., R. Chang, D. V. Debabov, J. Leung, T. Wu, K. M. Krause, E. Sandvik, J. M. Hubbard, K. Kaniga, D. E. Schmidt, Jr., Q. Gao, R. T. Cass, D. E. Karr, B. M. Benton, and P. P. Humphrey. 2005. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49:1127-1134.
7. Jefferson, K. K., D. A. Goldmann, and G. B. Pier. 2005. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 49:2467-2473.
8. Krause, K. M., M. Renelli, S. Difuntorum, T. X. Wu, D. V. Debabov, and B. M. Benton. 2008. In vitro activity of telavancin against resistant gram-positive bacteria. Antimicrob. Agents Chemother. 52:2647-2652.
9. Leuthner, K. D., C. M. Cheung, and M. J. Rybak. 2006. Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 58:338-343.
10. Lunde, C. S., S. R. Hartouni, J. W. Janc, M. Mammen, P. P. Humphrey, and B. M. Benton. 2009. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob. Agents Chemother. 53:3375-3383.
11. Lunde, C. S., C. H. Rexer, S. R. Hartouni, S. Axt, and B. M. Benton. 2009. Telavancin targets the division septum of Staphylococcus aureus: analysis of cellular binding by fluorescence microscopy, abstr. C1-1343. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA.
12. Pereira, P. M., S. R. Filipe, A. Tomasz, and M. G. Pinho. 2007. Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 51:3627-3633.
13. Pinho, M. G., and J. Errington. 2003. Dispersed mode of Staphylococcus aureus cell wall synthesis in the absence of the division machinery. Mol. Microbiol. 50:871-881.
14. Pinho, M. G., and J. Errington. 2005. Recruitment of penicillin-binding protein PBP2 to the division site of Staphylococcus aureus is dependent on its transpeptidation substrates. Mol. Microbiol. 55:799-807.
15. Scheffers, D. J., and M. G. Pinho. 2005. Bacterial cell wall synthesis: new insights from localization studies. Microbiol. Mol. Biol. Rev. 69:585-607.
16. Sieradzki, K., M. G. Pinho, and A. Tomasz. 1999. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. 274:18942-18946.
17. Tiyanont, K., T. Doan, M. B. Lazarus, X. Fang, D. Z. Rudner, and S. Walker. 2006. Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics. Proc. Natl. Acad. Sci. U. S. A. 103:11033-11038.
18. van Heijenoort, J. 2007. Lipid intermediates in the biosynthesis of bacterial peptidoglycan. Microbiol. Mol. Biol. Rev. 71:620-635.